AFRIGEN
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

AFRIGEN Trademark

Serial Number: 98209261 • Registration: 7954421

AFRIGEN is a trademark filed by AFRIGEN BIOLOGICS (PROPRIETARY) LIMITED on October 4, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

AFRIGEN BIOLOGICS (PROPRIETARY) LIMITED (4 trademarks)

Unit 5 & 6 Kestrel Park, Longclaw
Western Cape 7441 , ZA

Entity Type: 99

Trademark Details

Filing Date

October 4, 2023

Registration Date

September 23, 2025

Published for Opposition

January 7, 2025

Goods & Services

Pharmaceutical preparations for the treatment and prevention of inflammation, pain, anxiety, restlessness and stress; Veterinary pharmaceutical preparations for the treatment of inflammation, pain, anxiety, restlessness and stress; Veterinary preparations, namely, antioxidants; Pharmaceutical preparations for the treatment of sleeplessness and concentration disorders; Veterinary preparations for the treatment of sleeplessness and concentration disorders; Medicated cosmetics; Medicinal herbal extracts, other than essential oils, for medical purposes, namely, medicinal herbal extracts for relieving pain, improving sleep, improving concentration, relieving anxiety, relieving restlessness, and reducing muscular tension; Anti-inflammatory preparations, namely, medicinal herbal extracts, other than essential oils, for medical purposes particularly relieving pain, improving sleep, improving concentration, relieving anxiety, relieving restlessness, and reducing muscular tension; Medicinal herbal extracts, other than essential oils, for medical purposes, namely, medicinal herbal extracts that contain antioxidants; dietary and nutritional supplements, namely, magnesium, zinc, folic acid supplements; vitamins and vitamin preparations, namely, vitamin B12, vitamin D1, vitamin D3; Topical anesthetics; Medicated skin care preparations, namely, topical foams, gels, creams, sprays, lotions and ointments which act as a base and prepare the skin to receive therapeutic preparations that are absorbed into the blood stream through the skin; Pharmaceutical preparations, namely, a drug delivery system comprising topical foams, gels, creams, sprays, lotions and ointments which act as a base and prepare the skin to receive therapeutic preparations that are absorbed into the blood stream through the skin; analgesic preparations; antibiotic preparations

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 23, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 23, 2025 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Sep 2, 2025 DP1B
NOTICE OF ALLOWANCE CANCELLED
Apr 17, 2025 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Apr 17, 2025 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 10, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 8, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 26, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 30, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 30, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 30, 2024 CNRT
ASSIGNED TO EXAMINER
May 23, 2024 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 5, 2024 AMPX
ASSIGNED TO LIE
Mar 5, 2024 ALIE
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 14, 2023 MDSC
TEAS VOLUNTARY AMENDMENT RECEIVED
Oct 13, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 13, 2023 NWOS
NEW APPLICATION ENTERED
Oct 7, 2023 NWAP